Chemical Technology

Predictive Maintenance for Chemical Plants

April 4, 2022

Predictive Maintenance
Production processes used in the chemical industry often involve reactive, corrosive, or toxic chemicals operating at high pressures and temperatures. 

Spotlight

Vertex Pharmaceuticals

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ 2,100 people in the United States, Europe, Canada and Australia with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science magazine, The Boston Globe, Boston Business Journal and the San Diego Business Jou

OTHER WHITEPAPERS
news image

Development of Kinetic Models

whitePaper | August 26, 2022

safe storage, handling, and transportation of reactive chemicals is challenging. Characterization of both desired and undesired chemistries requires a variety

Read More
news image

What to Know When Conveying and Feeding Calcium Carbonate in Plastics Compounding

whitePaper | May 11, 2021

This paper outlines the importance of correct design of a conveying and feeding system for calcium carbonate in plastics compounding operations and how it is not a trivial proposition because of the number of variables that affect the flow and different powders.

Read More
news image

Chain Reaction: Conquering Labeling Challenges in the Chemical Industry

whitePaper | February 28, 2020

Reversing the complexity of global labeling management in the chemicals industry, so that intensifying regulatory demands don’t encroach on international market opportunity Trust, transparency and, above all, the safety of process/supply-chain intermediaries and consumers, is of paramount importance to the global chemicals industry. Yet, increasingly-stringent regulations about product/substance-based declarations, hazard warnings, and use of mandatory safety statements and symbols, is taking its toll on international brands.

Read More
news image

Digital Lifecycle Excellence in the Energy & Utilities Industry

whitePaper | July 12, 2021

Learn how to apply physical and digital assets to deliver top performance across all categories. Today, modern energy and utility companies are faced with the complex task of getting more value from their physical assets and supporting data to improve efficiency and reduce costs. Using a digital lifecycle excellence approach to organize and consolidate that data will provide opportunities to increase competitiveness across your organization.

Read More
news image

Technologies for PFAS Assessment, Detection,and Treatment

whitePaper | July 20, 2022

PFAS are a large group of heat and stain resistant chemicals, first developed in the 1940s. PFAS are used in a wide range of products, including carpet, nonstick cookware, waterproof clothing, and firefighting foam used at airports and military bases.

Read More
news image

Membrane development for large-scale hydrogen-bromine flow batteries

whitePaper | February 17, 2022

To bridge the gap between the current fossil fuel-based energy system and a future green system based on sustainable energy sources, the number of research activities in electrochemical energy storage technologies is increasing exponentially.

Read More

Spotlight

Vertex Pharmaceuticals

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ 2,100 people in the United States, Europe, Canada and Australia with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science magazine, The Boston Globe, Boston Business Journal and the San Diego Business Jou

Events